Announcements Trials
Browse Landscape

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Leukemia, Myeloid, Acute 387Leukemia 339Hematologic Neoplasms 313Leukemia, Lymphocytic, Chronic, B-Cell 215Lymphoma 142Leukemia, Myelogenous, Chronic, BCR-ABL Positive 140Neoplasms 115Myelodysplastic Syndromes 108Multiple Myeloma 98Lymphoma, Non-Hodgkin 95Hodgkin Disease 60Lymphoma, Large B-Cell, Diffuse 56Lymphoma, Follicular 56Congenital Abnormalities 52Lymphoma, Mantle-Cell 49Burkitt Lymphoma 48Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Chronic-Phase 45Myeloproliferative Disorders 42Leukemia, Myelomonocytic, Chronic 41Breast Neoplasms 41Leukemia, Hairy Cell 36Recurrence 35Lung Neoplasms 33Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 32Neoplasms, Plasma Cell 31Lymphoma, T-Cell, Cutaneous 31Lymphoma, Large-Cell, Immunoblastic 31Waldenstrom Macroglobulinemia 28

Interventions

Voriconazole 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Invasive Pulmonary Aspergillosis × Other hematologic neoplasm × Clear all
NCT06537726 2025-04-10

REDEFINE

University of Zurich

Recruiting
130 enrolled
LymphoidOther hematologic neoplasm

Invasive Fungal Infections, Leukemia, Leukemia, Myeloid, Neutropenia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Invasive Pulmonary Aspergillosis

NCT01148160 2014-04-10

Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

Asan Medical Center

Terminated
10 enrolled
Other hematologic neoplasm

Invasive Fungal Infections, Hematologic Neoplasms, Invasive Pulmonary Aspergillosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡